BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hanash S, Schliekelman M. Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers. Genome Med 2014;6:12. [PMID: 24713112 DOI: 10.1186/gm529] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Xu M, Ergin I, Beyaz S. Advances in Diagnostic Procedures and Their Applications in the Era of Cancer Immunotherapy. In: Naing A, Hajjar J, editors. Immunotherapy. Cham: Springer International Publishing; 2020. pp. 37-50. [DOI: 10.1007/978-3-030-41008-7_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Leszczynski D. The grand challenge: use of a new approach in developing policies in the area of radiation and health. Front Public Health 2014;2:50. [PMID: 24904914 DOI: 10.3389/fpubh.2014.00050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Ahmed I, Akram Z, Bule M, Iqbal H. Advancements and Potential Applications of Microfluidic Approaches—A Review. Chemosensors 2018;6:46. [DOI: 10.3390/chemosensors6040046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Etxebeste-Mitxeltorena M, Del Rincón-Loza I, Martín-Antonio B. Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner. Front Immunol 2021;12:717850. [PMID: 34447383 DOI: 10.3389/fimmu.2021.717850] [Reference Citation Analysis]
5 Suzuki Y, Takadate T, Mizuma M, Shima H, Suzuki T, Tachibana T, Shimura M, Hata T, Iseki M, Kawaguchi K, Aoki T, Hayashi H, Morikawa T, Nakagawa K, Motoi F, Naitoh T, Igarashi K, Unno M. Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma. PLoS One 2020;15:e0235904. [PMID: 32663208 DOI: 10.1371/journal.pone.0235904] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kuhlmann L, Cummins E, Samudio I, Kislinger T. Cell-surface proteomics for the identification of novel therapeutic targets in cancer. Expert Review of Proteomics 2018;15:259-75. [DOI: 10.1080/14789450.2018.1429924] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
7 Cheng G, Han X, Hao S, Nisic M, Zheng S. In Situ Caging of Biomolecules in Graphene Hybrids for Light Modulated Bioactivity. ACS Appl Mater Interfaces 2018;10:3361-71. [DOI: 10.1021/acsami.7b17544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Greening DW, Kapp EA, Simpson RJ. The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome. Enzymes 2017;42:27-64. [PMID: 29054270 DOI: 10.1016/bs.enz.2017.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zheng M, Wang J, Ling L, Xue D, Wang S, Zhao Y. Screening and analysis of breast cancer genes regulated by the human mammary microenvironment in a humanized mouse model. Oncol Lett 2016;12:5261-8. [PMID: 28101242 DOI: 10.3892/ol.2016.5310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Jallouk AP, Palekar RU, Marsh JN, Pan H, Pham CT, Schlesinger PH, Wickline SA. Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles. Bioconjug Chem 2015;26:1640-50. [PMID: 26083278 DOI: 10.1021/acs.bioconjchem.5b00246] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang X, Mooradian AD, Erdmann-Gilmore P, Zhang Q, Viner R, Davies SR, Huang KL, Bomgarden R, Van Tine BA, Shao J, Ding L, Li S, Ellis MJ, Rogers JC, Townsend RR, Fenyö D, Held JM. Breast tumors educate the proteome of stromal tissue in an individualized but coordinated manner. Sci Signal 2017;10:eaam8065. [PMID: 28790197 DOI: 10.1126/scisignal.aam8065] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
12 Sharma R, Gowda H, Chavan S, Advani J, Kelkar D, Kumar GSS, Bhattacharjee M, Chaerkady R, Prasad TSK, Pandey A, Nagaraja D, Christopher R. Proteomic Signature of Endothelial Dysfunction Identified in the Serum of Acute Ischemic Stroke Patients by the iTRAQ-Based LC–MS Approach. J Proteome Res 2015;14:2466-79. [DOI: 10.1021/pr501324n] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
13 da Cunha BR, Domingos C, Stefanini ACB, Henrique T, Polachini GM, Castelo-Branco P, Tajara EH. Cellular Interactions in the Tumor Microenvironment: The Role of Secretome. J Cancer 2019;10:4574-87. [PMID: 31528221 DOI: 10.7150/jca.21780] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
14 Roy J, Wycislo KL, Pondenis H, Fan TM, Das A. Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin. PLoS One 2017;12:e0183930. [PMID: 28910304 DOI: 10.1371/journal.pone.0183930] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
15 Kim BH, Yi EH, Ye SK. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment. Arch Pharm Res 2016;39:1085-99. [PMID: 27515050 DOI: 10.1007/s12272-016-0795-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
16 Arbab AS, Rashid MH, Angara K, Borin TF, Lin PC, Jain M, Achyut BR. Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma. Int J Mol Sci 2017;18:E2732. [PMID: 29258180 DOI: 10.3390/ijms18122732] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
17 Shukla SK, Sharma AK, Bajaj S, Yashavarddhan MH. Radiation proteome: a clue to protection, carcinogenesis, and drug development. Drug Discov Today 2021;26:525-31. [PMID: 33137481 DOI: 10.1016/j.drudis.2020.10.024] [Reference Citation Analysis]
18 Yue X, Nguyen TD, Zellmer V, Zhang S, Zorlutuna P. Stromal cell-laden 3D hydrogel microwell arrays as tumor microenvironment model for studying stiffness dependent stromal cell-cancer interactions. Biomaterials 2018;170:37-48. [DOI: 10.1016/j.biomaterials.2018.04.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
19 Sun YJ, Hsu CH, Ling TY, Liu L, Lin TC, Jakfar S, Young IC, Lin FH. The preparation of cell-containing microbubble scaffolds to mimic alveoli structure as a 3D drug-screening system for lung cancer. Biofabrication 2020;12:025031. [PMID: 32084662 DOI: 10.1088/1758-5090/ab78ee] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Gowthami J, Gururaj N, Mahalakshmi V, Sathya R, Sabarinath TR, Doss DM. Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic review. J Oral Maxillofac Pathol 2020;24:293-307. [PMID: 33456239 DOI: 10.4103/jomfp.JOMFP_348_19] [Reference Citation Analysis]
21 Pandey S, Robertson ES. Oncogenic Epstein-Barr virus recruits Nm23-H1 to regulate chromatin modifiers. Lab Invest 2018;98:258-68. [PMID: 29035376 DOI: 10.1038/labinvest.2017.112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]